Trial Profile
Study on the Drug Interaction of HS-10234 and Emtricitabine in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine (Primary) ; Tenofovir amibufenamide (Primary)
- Indications Hepatitis B
- Focus Pharmacokinetics
- Sponsors Jiangsu Hansoh Pharmaceutical
- 29 Sep 2020 Status changed from not yet recruiting to completed.
- 22 Jul 2020 New trial record